hVIVO Whitechapel Clinic

(35)

hVIVO - introduction to our quarantine \u0026 medical facilities, Oct 2016

(7:4)

hVIVO partners with ILiAD Biotechnologies for pivotal Phase 3 human challenge trial

(6:24)

hVIVO Canary Wharf Facilities - Adam French

(4:8)

FluCamp Clinical Trials by hVIVO

(1:7)

hVIVO Canary Wharf move to deliver material increase in capacity - Proactive Research Analyst

(3:26)

Lab Accreditation Awarded to hVIVO

(2:45)

hVIVO £14.7m Challenge virus manufacturing contract for top 5 global pharmaceutical client

(6:4)

Q\u0026A with hVIVO’s Mo Khan

(5:49)

Whitechapel - Vicer Exciser and Ear to Ear Live

(6:43)

hVIVO secure MHRA approval to start Codagenix COVID-19 Phase I Vaccine Trial - BRR Media

(1:19)

Open Orphan PLC on hVIVO signing its first phase 2 field study contract

(5:55)

Open Orphan's CEO on hVIVO's first ever Phase II field study site study awarded

(5:43)

Open Orphan's Cathal Friel on the 'large opportunity' for hVIVO subsidiary malaria study

(3:1econd)

hVIVO's Mo Khan on the company’s breakthrough year

(10:48)

Year in Review 2021 - Open Orphan

(2:1econd)

Cathal Friel \u0026 BRR Media Interview following £4m contract with top 3 Pharma company

(3:51)

Open Orphan hail £5m contract for new flu jab challenge study

(3:9)

Open Orphan subsidiary hVIVO launch of STRiVE to 'find out what people are actually suffering from'

(7:42)

Adrian Wildfire on hVIVO STRiVE Project

(8:6)

FluCamp - find out about the experience here

(7:29)

CEO Yamin 'Mo' Khan on £5m RSV Challenge Study Contract

(3:45)

hVIVO secures £6.3 million challenge contract

(4:11)

hVIVO to develop first commercial hMPV human challenge model

(5:4)

Alex Mann discusses hVIVO's new Influenza contract - BRR Media

(4:30)

Hvivo Q\u0026A: “this contract is important as it opens up new markets”

(10:19)

hVIVO announces move to \

(6:11)

BRR Interview Cathal Friel on Malaria Human challenge agent

(2:43)

hVIVO Asian growth strategy bearing fruit with second 2023 contract win

(4:7)